Trial Profile

Second phase 2 trial of N, N-dimethyltryptamine in patients with treatment-resistant depression

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 01 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs N-N-dimethyltryptamine (Primary)
Indications Depressive disorders
Focus Adverse reactions

Most Recent Events

30 Mar 2022 Status changed from planning to recruiting, according to a Biomind Labs media release.
14 Mar 2022 New trial record
09 Mar 2022 According to a Biomind Labs media release, this trial will be conducted by the Dr. Draulio Araujo.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com